These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19156411)

  • 1. Nuclear imaging in cardiac amyloidosis.
    Glaudemans AW; Slart RH; Zeebregts CJ; Veltman NC; Tio RA; Hazenberg BP; Dierckx RA
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):702-14. PubMed ID: 19156411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear imaging modalities for cardiac amyloidosis.
    Bokhari S; Shahzad R; Castaño A; Maurer MS
    J Nucl Cardiol; 2014 Feb; 21(1):175-84. PubMed ID: 24162886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of amyloidosis: will the heart be the next target after the brain?
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial scintigraphic studies with 123I-MIBG, 201Tl and 99mTc-PYP in patients with cardiac amyloidosis].
    Fujii T; Tanaka M; Yazaki Y; Kitabayashi H; Koizumi T; Hongo M; Sekiguchi M; Itoh A; Gomi T; Yano K
    Kaku Igaku; 1997 Nov; 34(11):1033-9. PubMed ID: 9455044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scan findings of various myocardial SPECT agents in a case of amyloid polyneuropathy with suspected myocardial involvement.
    Arbab AS; Koizumi K; Toyama K; Arai T; Yoshitomi T; Araki T
    Ann Nucl Med; 1997 May; 11(2):139-41. PubMed ID: 9212894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal imaging using SPECT.
    Yamashina S; Yamazaki J
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):939-50. PubMed ID: 17268772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging cardiac innervation in amyloidosis.
    Slart RHJA; Glaudemans AWJM; Hazenberg BPC; Noordzij W
    J Nucl Cardiol; 2019 Feb; 26(1):174-187. PubMed ID: 28887775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of differential nuclear medicine modalities in patients with ATTR amyloidosis.
    Noordzij W; Glaudemans AW; Slart RH; Dierckx RA; Hazenberg BP
    Amyloid; 2012 Dec; 19(4):208-11. PubMed ID: 22913327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy.
    Tanaka M; Hongo M; Kinoshita O; Takabayashi Y; Fujii T; Yazaki Y; Isobe M; Sekiguchi M
    J Am Coll Cardiol; 1997 Jan; 29(1):168-74. PubMed ID: 8996310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.
    Kennel SJ; Stuckey A; McWilliams-Koeppen HP; Richey T; Wall JS
    Mol Imaging Biol; 2016 Aug; 18(4):483-9. PubMed ID: 26573301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis.
    Han S; Chong V; Murray T; McDonagh T; Hunter J; Poon FW; Gray HW; Neilly JB
    Eur J Haematol; 2007 Dec; 79(6):494-500. PubMed ID: 17983443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of
    Minamimoto R; Awaya T; Iwama K; Hotta M; Nakajima K; Hirai R; Okazaki O; Hiroi Y
    J Nucl Cardiol; 2020 Feb; 27(1):202-209. PubMed ID: 29589208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging in systemic amyloidosis.
    Sachchithanantham S; Wechalekar AD
    Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.
    Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA
    J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of myocardial amyloid deposits in cardiac amyloidosis by Tc-99m pyrophosphate myocardial SPECT: implication for medical treatment.
    Casset-Senon D; Secchi V; Arbeille P; Cosnay P
    Clin Nucl Med; 2005 Jul; 30(7):496-7. PubMed ID: 15965328
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT.
    Wall JS; Richey T; Williams A; Stuckey A; Osborne D; Martin E; Kennel SJ
    Mol Imaging Biol; 2012 Aug; 14(4):402-7. PubMed ID: 22042488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m (Tc-99m) diphosphono-propanedicarboxylic acid bone tracer uptake and Tc-99m sestamibi distribution in cardiac amyloidosis--a case report.
    Low YH; Ang ES; Goh AS; Sundram FX; Sin FL
    Ann Acad Med Singap; 1995 Nov; 24(6):898-901. PubMed ID: 8839006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and monitoring of amyloidosis.
    Hawkins PN
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis.
    Hongo M; Urushibata K; Kai R; Takahashi W; Koizumi T; Uchikawa S; Imamura H; Kinoshita O; Owa M; Fujii T
    Am Heart J; 2002 Jul; 144(1):122-9. PubMed ID: 12094198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.